Sign in

CIK 0001585364 · Large accelerated filer

PERRIGO Co plc

Sign in to watch
Ticker
PRGO
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Ireland
Entity type
operating
Phone
269-673-8451
Business address
THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
Former names
PERRIGO Co Ltd
  1. 4 Grant or award EVP, Chief Medical Officer acquired 9,028 shares (grant or award)
  2. 4 Grant or award EVP and CIO acquired 9,652 shares (grant or award)
  3. 4 Grant or award EVP & President CHCI acquired 19,445 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy EVP & CHRO bought 6,371 shares at an average $25.90 ($164,977)
  6. 4 Open-market buy CEO bought 9,500 shares at $26.54 ($252,168)
  7. 4 Open-market buy EVP & CHRO bought 5,550 shares at $31.01 ($172,106)
  8. 4 Open-market buy EVP & Chief Scientific Officer bought 2,040 shares at $29.34 ($59,854)
  9. 4 Open-market buy EVP & Chief Financial Officer bought 5,000 shares at $29.18 ($145,882)
  10. 4 Open-market buy CEO bought 11,000 shares at $28.99 ($318,868)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Derivatives Options or other derivatives
  13. 4 Option exercise EVP & Chief Scientific Officer acquired 738 shares (option exercise)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Option exercise Director acquired 5,478 shares (option exercise)
  16. 4 Derivatives Options or other derivatives
  17. 4 Option exercise EVP & Chief Scientific Officer acquired 920 shares (option exercise)
  18. 4 Option exercise EVP & General Counsel acquired 12,409 shares (option exercise)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market buy Director bought 10,000 shares at $33.06 ($330,637)

Page 9 of 41 · 805 filings